CG Oncology said Phase 3 BOND-003 Cohort C results for its advanced bladder cancer therapy were published in The Lancet Oncology. The peer-reviewed study detail

CG Oncology said Phase 3 BOND-003 Cohort C results for its advanced bladder cancer therapy were published in The Lancet Oncology. The peer-reviewed study details complete response rates, duration of response and safety, marking a key clinical milestone.